To Evaluate Compliance to Treatment Regimen (Rate of Deviations From the Prescribed Regimen) in Polish Females Treated With Different Low Dose Oral Contraceptives (DOC)

Bayer

Status: Completed

Conditions: Contraception

Treatments: Drug: EE/DRSP (Yasmin Product Family)

Study type: Observational

Funder types: Industry

Identifiers

NCT01198444

YA0712PL (Other Identifier)

14340

Details and patient eligibility

About

Adherence to the dosing scheme is the principal element of Combined Oral Contraceptives efficiency. On the other hand noncompliance seemed to be an inseparable element of any oral treatment. The aim of the study is to evaluate in everyday practice the relation between dosage errors and indicated factors, potentially influencing the compliance with the dosing scheme.

Enrollment: 11,884 patients

Sex: Female

Ages: 18 to 50 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients at the age of over 18 requiring contraception. The decisions would be made at the discretion of the attending physician.

Exclusion criteria

• According to official Summary of Product Characteristics (SmPC) contraindications.

Trial design

11,884 participants in 1 patient group

Group 1

Treatment:

Drug: EE/DRSP (Yasmin Product Family)